{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T18:42:56Z","timestamp":1715712176353},"reference-count":36,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>(Gilles Boire): It was both a pleasure and an honor to present the 2019 Dunlop-Dottridge Lecture. My co-author and I will now discuss benefits and pitfalls of biomarkers developed through emerging techniques, evaluated through the experiential perspective of a seasoned clinician, as they apply to the quest for biomarker identification in rheumatic diseases.<\/jats:p>","DOI":"10.3899\/jrheum.190375","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T12:15:20Z","timestamp":1561983320000},"page":"758-763","source":"Crossref","is-referenced-by-count":3,"title":["The 4-H of Biomarkers in Arthritis: A Lot of Help, Occasional Harm, Some Hype, Increasing Hope"],"prefix":"10.3899","volume":"46","author":[{"given":"Gilles","family":"Boire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugues","family":"Allard-Chamard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"2019080920150985000_46.7.758.1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113989"},{"key":"2019080920150985000_46.7.758.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.3651"},{"key":"2019080920150985000_46.7.758.3","unstructured":"FDA-NIH Biomarker Working Group . BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring, MD:FDA-NIH; 2016. [Internet. Accessed April 9, 2019.] Available from: www.ncbi.nlm.nih.gov\/books\/nbk326791"},{"key":"2019080920150985000_46.7.758.4","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R600007-MCP200"},{"key":"2019080920150985000_46.7.758.5","first-page":"9607582","article-title":"Bartonella endocarditis mimicking crescentic glomerulonephritis with pr3-ANCA positivity","volume":"2018","author":"Vercellone","year":"2018","journal-title":"Case Rep Nephrol"},{"key":"2019080920150985000_46.7.758.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.476"},{"key":"2019080920150985000_46.7.758.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev272"},{"key":"2019080920150985000_46.7.758.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140082"},{"key":"2019080920150985000_46.7.758.9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","article-title":"Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis","volume":"13","author":"Catrina","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2019080920150985000_46.7.758.10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0000000000000356","article-title":"Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis","volume":"29","author":"England","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 10","key":"2019080920150985000_46.7.758.11","first-page":"2983","article-title":"The changing faces of rheumatoid arthritis patients at presentation: a 20-year study","volume":"70","author":"Carrier","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2019080920150985000_46.7.758.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100677"},{"key":"2019080920150985000_46.7.758.13","doi-asserted-by":"publisher","DOI":"10.1038\/nature24286"},{"key":"2019080920150985000_46.7.758.14","doi-asserted-by":"crossref","first-page":"e00044","DOI":"10.1128\/MMBR.00044-18","article-title":"Cross-domain and viral interactions in the microbiome","volume":"83","author":"Rowan-Nash","year":"2019","journal-title":"Microbiol Mol Biol Rev"},{"key":"2019080920150985000_46.7.758.15","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3389\/fimmu.2018.02425","article-title":"A single-cell sequencing guide for immunologists","volume":"9","author":"See","year":"2018","journal-title":"Front Immunol"},{"key":"2019080920150985000_46.7.758.16","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188503"},{"key":"2019080920150985000_46.7.758.17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/BOR.0000000000000471","article-title":"Epigenetics of inflammatory arthritis","volume":"30","author":"Hammaker","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2019080920150985000_46.7.758.18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-3283-2_1","article-title":"Systems medicine: Sketching the landscape","volume":"1386","author":"Kirschner","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2019080920150985000_46.7.758.19","doi-asserted-by":"crossref","unstructured":"Plant D Maciejewski M Smith S Nair N Maximising Therapeutic Utility in Rheumatoid Arthritis Consortium - the RAMS Study Group Hyrich K Profiling of gene expression biomarkers as a classifier of methotrexate nonresponse in patients with rheumatoid arthritis. Arthritis Rheumatol 2019 Jan 7 (E-pub ahead of print).","DOI":"10.1002\/art.40810"},{"key":"2019080920150985000_46.7.758.20","doi-asserted-by":"crossref","first-page":"e0208534","DOI":"10.1371\/journal.pone.0208534","article-title":"Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis","volume":"13","author":"de Rotte","year":"2018","journal-title":"PLoS One"},{"key":"2019080920150985000_46.7.758.21","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2019080920150985000_46.7.758.22","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1002\/art.38875","article-title":"The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis","volume":"66","author":"Eng","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2019080920150985000_46.7.758.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008"},{"key":"2019080920150985000_46.7.758.24","unstructured":"Institute of Medicine . Evaluation of biomarkers and surrogate endpoints in chronic disease. Micheel CM Ball JR , editors. Washington, DC: The National Academies Press; 2010."},{"key":"2019080920150985000_46.7.758.25","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4185"},{"key":"2019080920150985000_46.7.758.26","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3390\/jcm6060060","article-title":"Role of gut microbiota in rheumatoid arthritis","volume":"6","author":"Maeda","year":"2017","journal-title":"J Clin Med"},{"key":"2019080920150985000_46.7.758.27","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fimmu.2018.01525","article-title":"Attenuation of rheumatoid inflammation by sodium butyrate through reciprocal targeting of HDAC2 in osteoclasts and HDAC8 in T cells","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol"},{"key":"2019080920150985000_46.7.758.28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/nu10101499","article-title":"Impact of diet-modulated butyrate production on intestinal barrier function and inflammation","volume":"10","author":"Knudsen","year":"2018","journal-title":"Nutrients"},{"key":"2019080920150985000_46.7.758.29","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.58"},{"key":"2019080920150985000_46.7.758.30","first-page":"7","article-title":"Butyric acid: Pharmacological aspects and routes of administration","volume":"1","author":"Spina","year":"2007","journal-title":"Dig Liver Dis Suppl"},{"key":"2019080920150985000_46.7.758.31","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"2019080920150985000_46.7.758.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23198-5"},{"key":"2019080920150985000_46.7.758.33","doi-asserted-by":"crossref","unstructured":"Mandl KD Manrai AK . Potential excessive testing at scale: biomarkers, genomics, and machine learning. JAMA 2019 Feb 8 (E-pub ahead of print).","DOI":"10.1001\/jama.2019.0286"},{"key":"2019080920150985000_46.7.758.34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154252"},{"key":"2019080920150985000_46.7.758.35","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jamainternmed.2016.6210","article-title":"The medicalization of common conditions","volume":"176","author":"Redberg","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2019080920150985000_46.7.758.36","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.90"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T23:16:03Z","timestamp":1565392563000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.3899\/jrheum.190375"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190375","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}